TABLE 2.
Strain | Antibiotic resistancea | Plasmid DNAb | Slime productionc | Clumpingd
|
PCRb
|
Hybridization with prgBb | |||
---|---|---|---|---|---|---|---|---|---|
JH2-2 | OGIRF | agg | prgB | prgX | |||||
E. faecalis | |||||||||
EFS-12 | Tc, Em, Sm, Gm, Cl | + | SP | − | − | + | + | − | + |
EFS-13 | Tc, Em, Sm, Gm, Cl | + | NP | − | − | − | − | ND | ND |
EFS-16 | Tc, Em, Gm, Cl | + | SP | − | − | − | − | ND | ND |
EFS-20 | Em, Gm | + | SP | − | − | + | + | − | + |
EFS-22 | Tc, Em | − | NP | − | − | − | − | ND | ND |
EFS-27b | Tc, Gm, Cl | + | NP | +++ | ++ | + | + | − | + |
EFS-28b | Em, Gm | + | SP | − | − | + | + | − | + |
EFS-30d | Em | + | SP | +++ | − | + | + | − | + |
EFS-32 | Em, Gm | − | SP | − | − | − | − | ND | ND |
EFS-35 | Tc, Em | + | SP | − | − | − | − | ND | ND |
EGL-19 | Tc, Em, Gm, Cl | + | SP | − | + | + | + | − | + |
EFS-38 | Tc, Em, Gm, Cl | + | SP | − | + | − | − | ND | − |
OGIRF(pCF10) | Tc, Rf, Fu | + | NDe | +++ | − | + | + | + | + |
E. faecium | |||||||||
EFM-13 | Tc, Gm | + | NP | − | − | − | − | ND | ND |
EFM-14 | Em, Gm | − | NP | − | − | − | − | ND | ND |
EFM-15 | Em, Gm | − | NP | − | − | − | − | ND | ND |
EFM-26 | Tc, Em, Gm, Am | + | NP | + | + | − | − | ND | − |
EFM-33 | Tc, Em | − | NP | − | − | − | − | ND | ND |
CIUM-22 | Tc, Em, Cl, Am | − | NP | + | − | − | − | ND | − |
CIUM-34 | Tc, Am | − | SP | + | + | − | − | ND | − |
LS10(pBRG1) | Vm | + | ND | + | − | + | − | ND | − |
Am, ampicillin; Cl, chloramphenicol; Em, erythromycin; Gm, gentamicin; Sm, streptomycin; Tc, tetracycline; Vm, vancomycin; Rf, rifampin; Fu, fusidic acid.
+, present; −, absent.
SP, strong producers (OD > 0.240); WP, weak producers (0.120 < OD < 0.240); NP, nonproducers (OD < 0.120).
+, weak; ++, moderate; +++, strong.
ND, not determined.